As of Apr 29
| -0.12 / -4.04%|
The 6 analysts offering 12-month price forecasts for Aegerion Pharmaceuticals Inc have a median target of 12.50, with a high estimate of 17.00 and a low estimate of 6.00. The median estimate represents a +338.60% increase from the last price of 2.85.
The current consensus among 7 polled investment analysts is to Buy stock in Aegerion Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.